Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 2938571)

Published in Behav Neural Biol on March 01, 1986

Authors

W W Beatty, N Butters, D S Janowsky

Articles citing this

Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology (2010) 2.74

Mechanisms underlying working memory for novel information. Trends Cogn Sci (2006) 1.56

Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol (2005) 1.48

Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology (2010) 1.46

Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc (2008) 1.32

The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav (2011) 1.07

Cholinergic modulation of cognitive processing: insights drawn from computational models. Front Behav Neurosci (2012) 0.98

Leveraging the cortical cholinergic system to enhance attention. Neuropharmacology (2012) 0.96

Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps. Psychopharmacology (Berl) (2008) 0.92

Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat. Learn Mem (2010) 0.88

Antidepressant use and cognitive deficits in older men: addressing confounding by indications with different methods. Ann Epidemiol (2011) 0.87

Inhibitory Effects of Eucommia ulmoides Oliv. Bark on Scopolamine-Induced Learning and Memory Deficits in Mice. Biomol Ther (Seoul) (2013) 0.84

Comparative study of korean white, red, and black ginseng extract on cholinesterase inhibitory activity and cholinergic function. J Ginseng Res (2011) 0.83

WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behav Brain Res (2010) 0.82

Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects. Br J Clin Pharmacol (2011) 0.81

Cognitive enhancement following acute losartan in normotensive young adults. Psychopharmacology (Berl) (2011) 0.79

Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in Vitro. Mar Drugs (2016) 0.78

Catalpol Induces Neuroprotection and Prevents Memory Dysfunction through the Cholinergic System and BDNF. Evid Based Complement Alternat Med (2013) 0.77

Antiamnesic Effects of Walnuts Consumption on Scopolamine-Induced Memory Impairments in Rats. Basic Clin Neurosci (2015) 0.75

Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats. Adv Pharmacol Sci (2015) 0.75

Deer bone extract prevents against scopolamine-induced memory impairment in mice. J Med Food (2014) 0.75

Neuroprotective and Antiamnesic Effects of Mitragyna inermis Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice. Behav Neurol (2017) 0.75

Articles by these authors

(truncated to the top 100)

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology (1994) 5.81

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38

Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04

Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol (1991) 2.89

Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1992) 2.19

Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging. Clinical and neuropsychological significance. Arch Gen Psychiatry (1990) 2.18

Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn (1992) 1.98

A cholinergic-adrenergic hypothesis of mania and depression. Lancet (1972) 1.97

Semantic memory impairment in Alzheimer's disease: failure of access or degraded knowledge? Neuropsychologia (1992) 1.82

Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res (1991) 1.71

Dementia in institutionalized elderly: relation to sleep apnea. J Am Geriatr Soc (1991) 1.67

Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry (1995) 1.64

Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Arch Neurol (1986) 1.54

Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. II. Frontal lobe afferents. Brain Res (1975) 1.47

Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. J Neurosci (1989) 1.46

Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry (1994) 1.45

Cortical afferents to the entorhinal cortex of the Rhesus monkey. Science (1972) 1.45

Chlorpromazine reversal of the antihypertensive action of guanethidine. Lancet (1971) 1.43

Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology (1995) 1.42

Factors affecting chlorpromazine plasma levels in psychiatric patients. Arch Gen Psychiatry (1970) 1.42

Acetylcholine and depression. Psychosom Med (1974) 1.41

Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology (1990) 1.38

Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn (1996) 1.36

Cerebral structure on MRI, Part II: Specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry (1991) 1.32

Impaired learning of a motor skill in patients with Huntington's disease. Behav Neurosci (1988) 1.32

Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl) (1999) 1.30

Association between preference for sweets and excessive alcohol intake: a review of animal and human studies. Alcohol Alcohol (1999) 1.30

Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol (1992) 1.27

Effect of parietal lobe damage on the performance of reversible operations in space. Neuropsychologia (1970) 1.23

Cognitive loss and recovery in long-term alcohol abusers. Arch Gen Psychiatry (1983) 1.23

Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol Behav (1993) 1.21

Dimensionality and clustering in the semantic network of patients with Alzheimer's disease. Psychol Aging (1993) 1.20

Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. J Clin Exp Neuropsychol (1990) 1.20

Gonadal hormones and sex differences in nonreproductive behaviors in rodents: organizational and activational influences. Horm Behav (1979) 1.20

Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group. J Clin Exp Neuropsychol (1994) 1.20

Neurobiology of skill and habit learning. Curr Opin Neurobiol (1995) 1.20

Magnetic resonance imaging of alcoholic Korsakoff patients. Neuropsychopharmacology (1991) 1.19

Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol (1995) 1.18

Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics. Alcohol Clin Exp Res (1994) 1.17

Social deprivation and play in rats. Behav Neural Biol (1980) 1.16

Differential impairment of semantic and episodic memory in Alzheimer's and Huntington's diseases: a controlled prospective study. J Neurol Neurosurg Psychiatry (1990) 1.16

Generation of a high-density rat EST map. Genome Res (2001) 1.15

Cortical and subcortical influences on clustering and switching in the performance of verbal fluency tasks. Neuropsychologia (1998) 1.14

Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol (1994) 1.14

Verbal memory deficits associated with major affective disorders: a comparison of unipolar and bipolar patients. J Affect Disord (1987) 1.14

The nature of the naming deficit in Alzheimer's and Huntington's disease. Brain (1991) 1.12

Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry (1973) 1.11

The effect of lithium carbonate on the cognitive functions of normal subjects. Arch Gen Psychiatry (1977) 1.10

Saccharin intake predicts ethanol intake in genetically heterogeneous rats as well as different rat strains. Alcohol Clin Exp Res (1993) 1.10

Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Ann Neurol (1988) 1.09

The subcortical dysfunction hypothesis of memory deficits in depression: neuropsychological validation in a subgroup of patients. J Clin Exp Neuropsychol (1992) 1.08

An assessment of verbal recall, recognition and fluency abilities in patients with Huntington's disease. Cortex (1986) 1.06

Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Arch Neurol (1978) 1.06

An assessment of olfactory deficits in patients with damage to prefrontal cortex. Neuropsychologia (1980) 1.06

Behavioral effects of sequential and one-stage ablations of orbital prefrontal cortex in the monkey. Exp Neurol (1973) 1.06

Retrieval from semantic memory and its implications for Alzheimer's disease. J Exp Psychol Learn Mem Cogn (1995) 1.05

Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats. Physiol Behav (1995) 1.04

The dissociation of anterograde and retrograde amnesia in a patient with herpes encephalitis. J Clin Exp Neuropsychol (1992) 1.04

The deterioration of semantic memory in Alzheimer's disease. Can J Exp Psychol (1999) 1.04

Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Alcohol Clin Exp Res (1996) 1.03

Learning and memory impairments in young and old alcoholics: evidence for the premature-aging hypothesis. Alcohol Clin Exp Res (1980) 1.02

Spatial memory in rats: time course of working memory and effect of anesthetics. Behav Neural Biol (1980) 1.02

Memory disorders associated with Huntington's disease: verbal recall, verbal recognition and procedural memory. Neuropsychologia (1985) 1.02

Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology (1995) 1.01

Effect of iprindole on amine uptake in man. Arch Gen Psychiatry (1972) 1.01

Dissociations between skill learning and verbal recognition in amnesia and dementia. Arch Neurol (1984) 1.01

Sex-dependent effects of amygdaloid lesions on the social play of prepubertal rats. Physiol Behav (1981) 1.01

Cognitive functioning in men social drinkers; a replication study. J Stud Alcohol (1982) 1.01

Three screening batteries to detect cognitive impairment in multiple sclerosis. Mult Scler (2002) 1.00

Temporal gradients in the retrograde amnesia of patients with alcoholic Korsakoff's disease. Arch Neurol (1979) 1.00

Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression. Pharmacol Biochem Behav (1998) 0.99

Chlorpromazine: effects of antacids on its gastrointestinal absorption. J Clin Pharmacol (1973) 0.99

Psychomotor stimulants, social deprivation and play in juvenile rats. Pharmacol Biochem Behav (1982) 0.99

Longitudinal examination of American National Adult Reading Test (AMNART) performance in dementia of the Alzheimer type (DAT): validation and correction based on degree of cognitive decline. J Clin Exp Neuropsychol (1996) 0.99

The deterioration of semantic networks in patients with Alzheimer's disease: a cross-sectional study. Neuropsychologia (1997) 0.98

Hormonal determinants of sex differences in avoidance behavior and reactivity to electric shock in the rat. J Comp Physiol Psychol (1970) 0.97

Effect of L-DOPA on depression. Lancet (1969) 0.97

Differentiation of Alzheimer's disease and Huntington's disease with the Dementia Rating Scale. Arch Neurol (1989) 0.96

Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry (1995) 0.96

Cholinergic challenges in affective illness: behavioral and neuroendocrine correlates. J Clin Psychopharmacol (1981) 0.95

Longitudinal analysis of clock drawing in Alzheimer's disease patients. Brain Cogn (1996) 0.95

Memory for verbal information in individuals with HIV-associated dementia complex. HNRC Group. J Clin Exp Neuropsychol (1997) 0.95

An assessment of the semantic network in patients with Alzheimer's disease. J Cogn Neurosci (1993) 0.95

Suppression of play fighting by amphetamine: effects of catecholamine antagonists, agonists and synthesis inhibitors. Pharmacol Biochem Behav (1984) 0.95

The efficacy of azathioprine in relapsing-remitting multiple sclerosis. Neurology (1991) 0.94

Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile. Arch Neurol (1996) 0.93

Cognitive performance of alcoholics: a longitudinal evaluation of the role of drinking history, depression, liver function, nutrition, and family history. Alcohol Clin Exp Res (1991) 0.93

Lithium carbonate and ethanol induced "highs" in normal subjects. Arch Gen Psychiatry (1977) 0.93

Chlorpromazine plasma levels and effects. Arch Gen Psychiatry (1970) 0.93

The diagnostic utility of savings scores: differentiating Alzheimer's and Huntington's diseases with the logical memory and visual reproduction tests. J Clin Exp Neuropsychol (1993) 0.93

Recognition and naming of famous faces in Alzheimer's disease: a cognitive analysis. Neuropsychologia (1993) 0.93

A comparison of the category fluency deficits associated with Alzheimer's and Huntington's disease. Brain Lang (1989) 0.93

Further evidence for a continuum-of-impairment encompassing male alcoholic Korsakoff patients and chronic alcoholic men. Alcohol Clin Exp Res (1980) 0.92

Effects of anesthesia on patients taking psychotropic drugs. J Clin Psychopharmacol (1981) 0.92

Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology (1994) 0.92

Cholinergic reversal of manic symptoms. Lancet (1972) 0.91

Random number generation in dementia of the Alzheimer type: a test of frontal executive functions. Neuropsychologia (1996) 0.91

Temporal boundary of the sensitive period for hormonal organization of social play in juvenile rats. Physiol Behav (1981) 0.91

Morphine-induced hyperexcitability in man. Anesthesiology (1979) 0.91